Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2018 , 2017 , 2016 (all articles may be found in search)

Did you know how medwireNews writes our articles?

Filter

Date Title Topic
26 Jun 2019 Toripalimab Therapy May Be Feasible For Advanced Gastric Cancer Patients Gastric Cancer - Clinical Research - Immunotherapy
25 Jun 2019 Corticosteroid Link To NSCLC Immunotherapy Response Challenged Non-Small Cell Lung Cancer - Immunotherapy
24 Jun 2019 Pexidartinib Achieves ‘Robust’ Response In Tenosynovial Giant Cell Tumour Patients Soft Tissue Sarcomas - Clinical Research - Anticancer Agents
21 Jun 2019 Negative Results Reported For ECHO-301/KEYNOTE-252 Trial Melanoma - Clinical Research - Immunotherapy
20 Jun 2019 Niraparib Plus Pembrolizumab ‘Promising’ For Advanced TNBC, Ovarian Cancer Breast Cancer - Ovarian Cancer - Clinical Research - Anticancer Agents - Immunotherapy
19 Jun 2019 Adjuvant Afatinib ‘Not Recommended’ For Head And Neck Cancer Head and Neck Cancers - Anticancer Agents - Radiation Oncology
18 Jun 2019 Chemoradiotherapy Does Not Boost Relapse-Free Survival In Locally Advanced Endometrial Cancer Endometrial Cancer - Anticancer Agents - Radiation Oncology
17 Jun 2019 Enfortumab Vedotin Achieves ‘Substantial Clinical Activity’ In Advanced Urothelial Cancer Urothelial Cancers - Clinical Research - Anticancer Agents
14 Jun 2019 Early Positive Findings For ONC201 Therapy In H3 K27M-Mutant Glioma Central Nervous System Malignancies - Clinical Research - Anticancer Agents
13 Jun 2019 Lurbinectedin Shows SCLC Promise, Metformin Fails To Improve NSCLC Survival Thoracic Malignancies - Small Cell Lung Cancer - Non-Small Cell Lung Cancer - Anticancer Agents
12 Jun 2019 Front-Line Pembrolizumab Plus Axitinib Superior For Clear Cell mRCC Subgroups Renal Cell Cancer - Anticancer Agents - Immunotherapy
11 Jun 2019 RELAY Trial Findings Point To Erlotinib Plus Ramucirumab For EGFR-Mutated Metastatic NSCLC Non-Small Cell Lung Cancer - Anticancer Agents
10 Jun 2019 Gefitinib–Chemotherapy Boosts Advanced EGFR-Mutated NSCLC Survival Non-Small Cell Lung Cancer - Anticancer Agents
07 Jun 2019 MONALEESA-7: Ribociclib Delivers OS Benefit For Premenopausal Advanced Breast Cancer Breast Cancer - Anticancer Agents
06 Jun 2019 Combining Clinical, Genetic Risk Improves Distant Recurrence Prognosis In Premenopausal Breast Cancer Breast Cancer - Personalised/Precision Medicine